Stoke Therapeutics Ownership 2024 | Who Owns Stoke Therapeutics Now?
Institutional Ownership
132.51%
Insider Ownership
4.52%
Retail Ownership
-37.04%
Institutional Holders
115.00
Stoke Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SKORPIOS TRUST | 23.45% | 99.89% | 10,843,681 | -3,600,000 | -24.92% | 146,498,130 | Jun 30, 2024 |
| BLACKROCK INC. | 11.70% | 0.00% | 5,409,169 | 1,550,706 | 40.19% | 73,077,872 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 11.21% | 25.39% | 5,185,191 | 1,488,371 | 40.26% | 70,051,931 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 10.21% | 3.86% | 4,721,054 | -351,995 | -6.94% | 63,781,440 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 9.45% | 0.75% | 4,368,443 | 1,000,000 | 29.69% | 59,017,665 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.14% | 0.88% | 4,224,838 | - | - | 57,077,561 | Jun 30, 2024 |
| MORGAN STANLEY | 7.52% | 0.00% | 3,478,797 | -546,205 | -13.57% | 46,998,549 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 7.28% | 1.25% | 3,365,744 | - | - | 45,471,201 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.81% | 0.00% | 2,687,658 | 972,104 | 56.66% | 36,310,260 | Jun 30, 2024 |
| STATE STREET CORP | 3.44% | 0.00% | 1,591,743 | 1,012,136 | 174.62% | 21,504,448,000 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 3.17% | 0.04% | 1,468,202 | 1,468,202 | 100.00% | 19,835,409 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3.00% | 0.05% | 1,387,200 | 1,123,500 | 426.05% | 18,741,072 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.96% | 0.00% | 1,367,517 | -36,538 | -2.60% | 18,475,155 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.63% | 0.01% | 1,216,200 | 157,900 | 14.92% | 16,430,862 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.51% | 0.02% | 1,161,037 | 982,451 | 550.13% | 15,685,610 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.27% | 1.15% | 1,050,000 | 1,050,000 | 100.00% | 14,185,500 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.72% | 0.00% | 794,170 | 154,363 | 24.13% | 10,731,632 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 1.29% | 0.32% | 598,401 | 122,938 | 25.86% | 8,084,398 | Jun 30, 2024 |
| INVESCO LTD. | 0.95% | 0.00% | 437,136 | 437,136 | 100.00% | 5,905,708 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.92% | 0.33% | 427,163 | - | - | 5,770,972 | Jun 30, 2024 |
Stoke Therapeutics's largest institutional shareholder is SKORPIOS TRUST, holding 23.45% of the company's total share outstanding, currently valued at $146.50M. The top 10 institutional shareholders own together 99.20% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SKORPIOS TRUST | 23.45% | 99.89% | 10,843,681 | -3,600,000 | -24.92% | 146,498,130 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 11.21% | 25.39% | 5,185,191 | 1,488,371 | 40.26% | 70,051,931 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 10.21% | 3.86% | 4,721,054 | -351,995 | -6.94% | 63,781,440 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.45% | 2.63% | 210,000 | - | - | 2,837,100 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 7.28% | 1.25% | 3,365,744 | - | - | 45,471,201 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.27% | 1.15% | 1,050,000 | 1,050,000 | 100.00% | 14,185,500 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.14% | 0.88% | 4,224,838 | - | - | 57,077,561 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 9.45% | 0.75% | 4,368,443 | 1,000,000 | 29.69% | 59,017,665 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.45% | 0.67% | 207,427 | 62,427 | 43.05% | 2,802,339 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.38% | 0.64% | 175,301 | -50,195 | -22.26% | 2,368,317 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.31% | 0.45% | 141,518 | 141,518 | 100.00% | 1,911,908 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.92% | 0.33% | 427,163 | - | - | 5,770,972 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 1.29% | 0.32% | 598,401 | 122,938 | 25.86% | 8,084,398 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 0.27% | 0.20% | 125,861 | - | - | 1,700,382 | Jun 30, 2024 |
| FORT POINT CAPITAL PARTNERS LLC | 0.16% | 0.13% | 75,429 | - | - | 1,019,046 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.08% | 0.08% | 37,637 | -8,208 | -17.90% | 508,476 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.13% | 0.06% | 61,277 | -228,723 | -78.87% | 827,852 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3.00% | 0.05% | 1,387,200 | 1,123,500 | 426.05% | 18,741,072 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 3.17% | 0.04% | 1,468,202 | 1,468,202 | 100.00% | 19,835,409 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.39% | 0.04% | 179,613 | 148,637 | 479.85% | 2,426,572 | Jun 30, 2024 |
The largest Stoke Therapeutics shareholder by % of total assets is SKORPIOS TRUST. The company owns 10.84M shares of Stoke Therapeutics (STOK), representing 99.89% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 11.70% | 0.00% | 5,409,169 | 1,550,706 | 40.19% | 73,077,872 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 11.21% | 25.39% | 5,185,191 | 1,488,371 | 40.26% | 70,051,931 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 3.17% | 0.04% | 1,468,202 | 1,468,202 | 100.00% | 19,835,409 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3.00% | 0.05% | 1,387,200 | 1,123,500 | 426.05% | 18,741,072 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.27% | 1.15% | 1,050,000 | 1,050,000 | 100.00% | 14,185,500 | Jun 30, 2024 |
| STATE STREET CORP | 3.44% | 0.00% | 1,591,743 | 1,012,136 | 174.62% | 21,504,448,000 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 9.45% | 0.75% | 4,368,443 | 1,000,000 | 29.69% | 59,017,665 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.51% | 0.02% | 1,161,037 | 982,451 | 550.13% | 15,685,610 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.81% | 0.00% | 2,687,658 | 972,104 | 56.66% | 36,310,260 | Jun 30, 2024 |
| INVESCO LTD. | 0.95% | 0.00% | 437,136 | 437,136 | 100.00% | 5,905,708 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.63% | 0.00% | 289,067 | 243,083 | 528.63% | 3,905,295 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.43% | 0.01% | 198,280 | 198,280 | 100.00% | 2,678,763 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.63% | 0.01% | 1,216,200 | 157,900 | 14.92% | 16,430,862 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.72% | 0.00% | 794,170 | 154,363 | 24.13% | 10,731,632 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.39% | 0.04% | 179,613 | 148,637 | 479.85% | 2,426,572 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.31% | 0.45% | 141,518 | 141,518 | 100.00% | 1,911,908 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.27% | 0.00% | 126,830 | 126,830 | 100.00% | 1,713,473 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 1.29% | 0.32% | 598,401 | 122,938 | 25.86% | 8,084,398 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.25% | 0.00% | 114,905 | 99,405 | 641.32% | 1,552,367 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.21% | 0.00% | 97,798 | 97,798 | 100.00% | 1,321,251 | Jun 30, 2024 |
As of Jun 30 2024, Stoke Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 1.55M stocks of STOK, valued at $73.08M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SKORPIOS TRUST | 23.45% | 99.89% | 10,843,681 | -3,600,000 | -24.92% | 146,498,130 | Jun 30, 2024 |
| MORGAN STANLEY | 7.52% | 0.00% | 3,478,797 | -546,205 | -13.57% | 46,998,549 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.03% | 0.00% | 16,030 | -396,210 | -96.11% | 216,565 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 10.21% | 3.86% | 4,721,054 | -351,995 | -6.94% | 63,781,440 | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.13% | 0.06% | 61,277 | -228,723 | -78.87% | 827,852 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -142,458 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -97,508 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -90,663 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -67,584 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.30% | 0.00% | 137,010 | -56,750 | -29.29% | 1,851,005 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.38% | 0.64% | 175,301 | -50,195 | -22.26% | 2,368,317 | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -41,600 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.96% | 0.00% | 1,367,517 | -36,538 | -2.60% | 18,475,155 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.03% | 0.00% | 15,042 | -36,055 | -70.56% | 203,217 | Jun 30, 2024 |
| SEVEN GRAND MANAGERS, LLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.41% | 0.00% | 191,360 | -28,405 | -12.93% | 2,584,693 | Jun 30, 2024 |
As of Jun 30 2024, Stoke Therapeutics's biggest institutional seller is SKORPIOS TRUST. The company sold -3.60M shares of STOK, valued at $146.50M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASSENAGON ASSET MANAGEMENT S.A. | 3.17% | 0.04% | 1,468,202 | 1,468,202 | 100.00% | 19,835,409 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.27% | 1.15% | 1,050,000 | 1,050,000 | 100.00% | 14,185,500 | Jun 30, 2024 |
| INVESCO LTD. | 0.95% | 0.00% | 437,136 | 437,136 | 100.00% | 5,905,708 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.43% | 0.01% | 198,280 | 198,280 | 100.00% | 2,678,763 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.31% | 0.45% | 141,518 | 141,518 | 100.00% | 1,911,908 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.27% | 0.00% | 126,830 | 126,830 | 100.00% | 1,713,473 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.17% | 0.00% | 79,885 | 79,885 | 100.00% | 1,079,246 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.14% | 0.00% | 66,400 | 66,400 | 100.00% | 897,064,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.12% | 0.00% | 57,399 | 57,399 | 100.00% | 775,461 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.10% | 0.00% | 44,205 | 44,205 | 100.00% | 597,210 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.07% | 0.01% | 34,277 | 34,277 | 100.00% | 463,082 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.06% | 0.01% | 27,924 | 27,924 | 100.00% | 377,253 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 19,133 | 19,133 | 100.00% | 258,487 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 18,900 | 18,900 | 100.00% | 254,961 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 17,651 | 17,651 | 100.00% | 237,863 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.03% | 0.01% | 14,893 | 14,893 | 100.00% | 201,204 | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 0.02% | 0.00% | 9,129 | 9,129 | 100.00% | 123,333,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.03% | 5,167 | 5,167 | 100.00% | 69,806 | Jun 30, 2024 |
| STRS OHIO | 0.01% | 0.00% | 2,300 | 2,300 | 100.00% | 31,073,000 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.00% | 0.00% | 2,110 | 2,110 | 100.00% | 28,506 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,527 | 1,527 | 100.00% | 20,630 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 454 | 454 | 100.00% | 6,134 | Jun 30, 2024 |
| US BANCORP \DE\ | 0.00% | - | 396 | 396 | 100.00% | 5,350 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 173 | 173 | 100.00% | 2,338 | Jun 30, 2024 |
| QUARRY LP | 0.00% | 0.00% | 118 | 118 | 100.00% | 1,594 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 110 | 110 | 100.00% | 1,000 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | 0.00% | 0.00% | 70 | 70 | 100.00% | 946 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 50 | 50 | 100.00% | 676 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 30 | 30 | 100.00% | 405 | Jun 30, 2024 |
Stoke Therapeutics's largest new institutional shareholder by number of shares is ASSENAGON ASSET MANAGEMENT S.A., purchased 1.47M shares, valued at $19.84M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -142,458 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -97,508 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -90,663 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -67,584 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -41,600 | -100.00% | - | Jun 30, 2024 |
| SEVEN GRAND MANAGERS, LLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| ZACKS INVESTMENT MANAGEMENT | - | - | - | -21,439 | -100.00% | - | Jun 30, 2024 |
| CHASE INVESTMENT COUNSEL CORP | - | - | - | -20,738 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -17,100 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -16,308 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -13,738 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -10,473 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -10,451 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -9,600 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -2,900 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,625 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -400 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
Stoke Therapeutics's largest sold out institutional shareholder by shares sold is ARTAL GROUP S.A., sold -0.30M shares, valued at -, as of undefined.
Stoke Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 0.48% | 118,269 | - | - | Dec 31, 2023 |
| Voya VARIABLE PRODUCTS TRUST | 0.08% | 30,422 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.08% | 68,508 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.07% | 222,554 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 30,755 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.06% | 150,491 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 446,619 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.05% | 133,770 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 594,000 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 14,884 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.02% | 60,000 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.02% | 20,628 | -7,386 | -26.37% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.02% | 4,406 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 40,163 | - | - | Feb 29, 2024 |
| Voya EQUITY TRUST | 0.01% | 17,592 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 13,995 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 47,895 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,277 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.01% | 6,000 | - | - | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.01% | 29,127 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 7,893 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 10,700 | - | - | Mar 28, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 19,090 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,428,266 | -362,684 | -20.25% | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 157,500 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 31,259 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 519 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 146,536 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 42,500 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 8,815 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 102,985 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 75,768 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 146,000 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 119,010 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 276,597 | 34,497 | 14.25% | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 5,500 | -20,810 | -79.10% | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 5,956 | - | - | Mar 31, 2020 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 247,361 | 70,750 | 40.06% | Jan 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 105,212 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,278 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 16,098 | 322 | 2.04% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 20,339 | -1,296 | -5.99% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 11,438 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,250 | -1,116 | -13.34% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 83,565 | - | - | Jan 31, 2024 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 18,070 | - | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 68,029 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 295 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,326 | -1,849 | -16.55% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1,387 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 67,804 | 352 | 0.52% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 140,945 | -2,516 | -1.75% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,137 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 622 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 9,461 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 22,497 | 3,991 | 21.57% | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 101 | - | - | Apr 30, 2021 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 2,970 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 2,458 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 24,500 | -1,458 | -5.62% | Mar 28, 2024 |
| Trust for Advised Portfolios | 0.00% | 3,253 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,900 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,429 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 3,817 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 3,227 | - | - | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 5,124 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 40,692 | 2,337 | 6.09% | Jan 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 7,534 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 454 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 88,458 | -55 | -0.06% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,001,747 | -58,819 | -5.55% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 252 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 119,539 | 13,578 | 12.81% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 8,980 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 54,519 | 44,055 | 421.01% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 4,657 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 1,486 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 4,136 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 39,040 | -8,057 | -17.11% | Jan 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 11,541 | 812 | 7.57% | Dec 31, 2023 |
| VALIC Co I | 0.00% | 10,586 | -43 | -0.40% | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 2,790 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,779 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,185 | -25,871 | -86.08% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 125 | - | - | Dec 31, 2023 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 10,578 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 12,506 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,208 | -35 | -1.08% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 700 | - | - | Mar 28, 2024 |
| Ultimus Managers Trust | 0.00% | 244 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 2,277 | - | - | Mar 28, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 113 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 216 | -15 | -6.49% | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 57,564 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 51,259 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,043 | -2,340 | -36.66% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 575,797 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 944 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 903 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 16 | - | - | Dec 31, 2023 |
Stoke Therapeutics's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 118.27K shares, compromising 0.48% of its total assets.
Stoke Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 115 | 4.55% |
| 31 Mar, 24 | 110 | 32.53% |
| 31 Dec, 23 | 83 | -17.00% |
| 30 Sep, 23 | 100 | -5.66% |
| 30 Jun, 23 | 106 | 7.07% |
| 31 Mar, 23 | 99 | -9.17% |
| 31 Dec, 22 | 109 | 3.81% |
| 30 Sep, 22 | 105 | 11.70% |
| 30 Jun, 22 | 94 | -6.93% |
| 31 Mar, 22 | 101 | 7.45% |
| 31 Dec, 21 | 94 | 3.30% |
| 30 Sep, 21 | 91 | -9.00% |
| 30 Jun, 21 | 100 | -9.09% |
| 31 Mar, 21 | 110 | 13.40% |
| 31 Dec, 20 | 97 | 5.43% |
| 30 Sep, 20 | 92 | 29.58% |
| 30 Jun, 20 | 71 | 5.97% |
| 31 Mar, 20 | 67 | 4.69% |
| 31 Dec, 19 | 64 | 23.08% |
| 30 Sep, 19 | 52 | 10.64% |
| 30 Jun, 19 | 47 | - |
As of 30 Jun 24, 115 institutions are holding Stoke Therapeutics's shares, representing an increase of 4.55% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 61,284,001 | 13.09% |
| 31 Mar, 24 | 54,189,692 | 20.45% |
| 31 Dec, 23 | 44,987,632 | 2.40% |
| 30 Sep, 23 | 43,931,099 | -5.62% |
| 30 Jun, 23 | 46,545,885 | 4.28% |
| 31 Mar, 23 | 44,636,193 | -92.16% |
| 31 Dec, 22 | 569,017,952 | 1246.04% |
| 30 Sep, 22 | 42,273,632 | -1.86% |
| 30 Jun, 22 | 43,073,664 | 4.16% |
| 31 Mar, 22 | 41,354,790 | 16.72% |
| 31 Dec, 21 | 35,431,412 | 83.14% |
| 30 Sep, 21 | 19,346,161 | -4.26% |
| 30 Jun, 21 | 20,207,432 | -47.39% |
| 31 Mar, 21 | 38,407,090 | -0.57% |
| 31 Dec, 20 | 38,626,516 | 11.54% |
| 30 Sep, 20 | 34,631,639 | -0.90% |
| 30 Jun, 20 | 34,945,269 | 1.11% |
| 31 Mar, 20 | 34,562,239 | 3.22% |
| 31 Dec, 19 | 33,483,548 | 110.12% |
| 30 Sep, 19 | 15,935,472 | 11.96% |
| 30 Jun, 19 | 14,232,585 | - |
Stoke Therapeutics (STOK) has 61.28M shares outstanding as of 30 Jun 24, up 13.09% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 132.51% | 0.97% |
| 31 Mar, 24 | 117.17% | 1.17% |
| 31 Dec, 23 | 100.06% | 1.02% |
| 30 Sep, 23 | 99.24% | 0.89% |
| 30 Jun, 23 | 105.33% | 0.96% |
| 31 Mar, 23 | 104.94% | 0.00% |
| 31 Dec, 22 | 1462.87% | 12.72% |
| 30 Sep, 22 | 107.24% | 0.89% |
| 30 Jun, 22 | 109.72% | 0.90% |
| 31 Mar, 22 | 110.43% | 1.19% |
| 31 Dec, 21 | 96.44% | 3.48% |
| 30 Sep, 21 | 52.63% | 1.74% |
| 30 Jun, 21 | 55.05% | 0.50% |
| 31 Mar, 21 | 104.81% | 0.78% |
| 31 Dec, 20 | 116.09% | 1.07% |
| 30 Sep, 20 | 104.08% | 0.93% |
| 30 Jun, 20 | 105.72% | 0.96% |
| 31 Mar, 20 | 105.06% | 1.01% |
| 31 Dec, 19 | 101.89% | 4.33% |
| 30 Sep, 19 | 48.49% | 1.32% |
| 30 Jun, 19 | 60.53% | - |
As of 30 Jun 24, Stoke Therapeutics is held by 132.51% institutional shareholders, representing a 0.97% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 82 | 17.14% |
| 31 Mar, 24 | 70 | 112.12% |
| 31 Dec, 23 | 33 | -23.26% |
| 30 Sep, 23 | 43 | -20.37% |
| 30 Jun, 23 | 54 | 58.82% |
| 31 Mar, 23 | 34 | -49.25% |
| 31 Dec, 22 | 67 | 24.07% |
| 30 Sep, 22 | 54 | 5.88% |
| 30 Jun, 22 | 51 | -12.07% |
| 31 Mar, 22 | 58 | 11.54% |
| 31 Dec, 21 | 52 | 57.58% |
| 30 Sep, 21 | 33 | -37.74% |
| 30 Jun, 21 | 53 | -10.17% |
| 31 Mar, 21 | 59 | 20.41% |
| 31 Dec, 20 | 49 | 22.50% |
| 30 Sep, 20 | 40 | 48.15% |
| 30 Jun, 20 | 27 | -34.15% |
| 31 Mar, 20 | 41 | -2.38% |
| 31 Dec, 19 | 42 | 13.51% |
| 30 Sep, 19 | 37 | -21.28% |
| 30 Jun, 19 | 47 | - |
82 institutional shareholders have increased their position in STOK stock as of 30 Jun 24 compared to 70 in the previous quarter (a 17.14% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 22 | -15.38% |
| 31 Mar, 24 | 26 | -18.75% |
| 31 Dec, 23 | 32 | -11.11% |
| 30 Sep, 23 | 36 | 28.57% |
| 30 Jun, 23 | 28 | -44.00% |
| 31 Mar, 23 | 50 | 72.41% |
| 31 Dec, 22 | 29 | -6.45% |
| 30 Sep, 22 | 31 | 47.62% |
| 30 Jun, 22 | 21 | -22.22% |
| 31 Mar, 22 | 27 | 3.85% |
| 31 Dec, 21 | 26 | -16.13% |
| 30 Sep, 21 | 31 | 19.23% |
| 30 Jun, 21 | 26 | 8.33% |
| 31 Mar, 21 | 24 | -4.00% |
| 31 Dec, 20 | 25 | -13.79% |
| 30 Sep, 20 | 29 | 20.83% |
| 30 Jun, 20 | 24 | 60.00% |
| 31 Mar, 20 | 15 | 36.36% |
| 31 Dec, 19 | 11 | 22.22% |
| 30 Sep, 19 | 9 | - |
| 30 Jun, 19 | - | - |
22 institutional shareholders have reduced their position in STOK stock as of 30 Jun 24 compared to 26 in the previous quarter (a -15.38% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 115 | 4.55% | 61,284,001 | 13.09% | 132.51% | 0.97% | 82 | 17.14% | 22 | -15.38% |
| 31 Mar, 24 | 110 | 32.53% | 54,189,692 | 20.45% | 117.17% | 1.17% | 70 | 112.12% | 26 | -18.75% |
| 31 Dec, 23 | 83 | -17.00% | 44,987,632 | 2.40% | 100.06% | 1.02% | 33 | -23.26% | 32 | -11.11% |
| 30 Sep, 23 | 100 | -5.66% | 43,931,099 | -5.62% | 99.24% | 0.89% | 43 | -20.37% | 36 | 28.57% |
| 30 Jun, 23 | 106 | 7.07% | 46,545,885 | 4.28% | 105.33% | 0.96% | 54 | 58.82% | 28 | -44.00% |
| 31 Mar, 23 | 99 | -9.17% | 44,636,193 | -92.16% | 104.94% | 0.00% | 34 | -49.25% | 50 | 72.41% |
| 31 Dec, 22 | 109 | 3.81% | 569,017,952 | 1246.04% | 1462.87% | 12.72% | 67 | 24.07% | 29 | -6.45% |
| 30 Sep, 22 | 105 | 11.70% | 42,273,632 | -1.86% | 107.24% | 0.89% | 54 | 5.88% | 31 | 47.62% |
| 30 Jun, 22 | 94 | -6.93% | 43,073,664 | 4.16% | 109.72% | 0.90% | 51 | -12.07% | 21 | -22.22% |
| 31 Mar, 22 | 101 | 7.45% | 41,354,790 | 16.72% | 110.43% | 1.19% | 58 | 11.54% | 27 | 3.85% |
| 31 Dec, 21 | 94 | 3.30% | 35,431,412 | 83.14% | 96.44% | 3.48% | 52 | 57.58% | 26 | -16.13% |
| 30 Sep, 21 | 91 | -9.00% | 19,346,161 | -4.26% | 52.63% | 1.74% | 33 | -37.74% | 31 | 19.23% |
| 30 Jun, 21 | 100 | -9.09% | 20,207,432 | -47.39% | 55.05% | 0.50% | 53 | -10.17% | 26 | 8.33% |
| 31 Mar, 21 | 110 | 13.40% | 38,407,090 | -0.57% | 104.81% | 0.78% | 59 | 20.41% | 24 | -4.00% |
| 31 Dec, 20 | 97 | 5.43% | 38,626,516 | 11.54% | 116.09% | 1.07% | 49 | 22.50% | 25 | -13.79% |
| 30 Sep, 20 | 92 | 29.58% | 34,631,639 | -0.90% | 104.08% | 0.93% | 40 | 48.15% | 29 | 20.83% |
| 30 Jun, 20 | 71 | 5.97% | 34,945,269 | 1.11% | 105.72% | 0.96% | 27 | -34.15% | 24 | 60.00% |
| 31 Mar, 20 | 67 | 4.69% | 34,562,239 | 3.22% | 105.06% | 1.01% | 41 | -2.38% | 15 | 36.36% |
| 31 Dec, 19 | 64 | 23.08% | 33,483,548 | 110.12% | 101.89% | 4.33% | 42 | 13.51% | 11 | 22.22% |
| 30 Sep, 19 | 52 | 10.64% | 15,935,472 | 11.96% | 48.49% | 1.32% | 37 | -21.28% | 9 | - |
| 30 Jun, 19 | 47 | - | 14,232,585 | - | 60.53% | - | 47 | - | - | - |
Stoke Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Stoke Therapeutics's stock was made by Ticho Barry on Aug 05 2024, selling 10,000 shares at $0.60 per share (valued at $6.00K).
Stoke Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 4 | 25.00% |
| Q2 2024 | 15 | 17 | 88.24% |
| Q1 2024 | 17 | 17 | 100.00% |
| Q4 2023 | 5 | 10 | 50.00% |
| Q3 2023 | 1 | 1 | 100.00% |
| Q2 2023 | 7 | 6 | 116.67% |
| Q1 2023 | 11 | 10 | 110.00% |
| Q4 2022 | 4 | - | - |
| Q2 2022 | 14 | 3 | 466.67% |
| Q1 2022 | 9 | 4 | 225.00% |
| Q4 2021 | 4 | 10 | 40.00% |
| Q3 2021 | 3 | 8 | 37.50% |
| Q2 2021 | 8 | 3 | 266.67% |
| Q1 2021 | 13 | 21 | 61.90% |
| Q4 2020 | 20 | 51 | 39.22% |
| Q3 2020 | 8 | 17 | 47.06% |
| Q2 2020 | 11 | 14 | 78.57% |
| Q1 2020 | 10 | 5 | 200.00% |
| Q4 2019 | 10 | 4 | 250.00% |
| Q3 2019 | 6 | - | - |
1 total buy trades, and 4 total sell trades (buy/sell ratio of 0.25%) were made by Stoke Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | - | 11 | - |
| Q1 2024 | - | 10 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | 5 | - |
| Q4 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 3 | - |
| Q4 2021 | - | 6 | - |
| Q3 2021 | - | 5 | - |
| Q2 2021 | - | 1 | - |
| Q1 2021 | - | 14 | - |
| Q4 2020 | 2 | 33 | 6.06% |
| Q3 2020 | - | 9 | - |
| Q2 2020 | - | 8 | - |
| Q1 2020 | - | 2 | - |
| Q4 2019 | 5 | 1 | 500.00% |
| Q3 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Stoke Therapeutics's stocks.
STOK Ownership FAQ
Who Owns Stoke Therapeutics?
Stoke Therapeutics is owned by institutional shareholders (132.51%), insiders (4.52%), and public (-37.04%). The largest institutional shareholder of Stoke Therapeutics is SKORPIOS TRUST (23.45% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (0.48% of total shares).
Who are the major institutional shareholders of Stoke Therapeutics?
Stoke Therapeutics's major institutional shareholders are SKORPIOS TRUST, BLACKROCK INC., LYNX1 CAPITAL MANAGEMENT LP, REDMILE GROUP, LLC, and BAKER BROS. ADVISORS LP. The top five shareholders own together 66.01% of the company's share outstanding.
How many Stoke Therapeutics shareholders are there?
As of Jun 2024, there are 115 institutional shareholders of Stoke Therapeutics.
What percentage of Stoke Therapeutics is owned by SKORPIOS TRUST?
SKORPIOS TRUST owns 10.84M shares of Stoke Therapeutics, representing 23.45% of the company's total shares outstanding, valued at $146.5M (as of Jun 2024).
What percentage of Stoke Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 5.41M shares of Stoke Therapeutics (STOK), compromising 11.70% of the company, valued at $73.08M.
What percentage of Stoke Therapeutics is owned by LYNX1 CAPITAL MANAGEMENT LP?
LYNX1 CAPITAL MANAGEMENT LP is the third largest holder of Stoke Therapeutics. The company owns 5.19M of the company's shares outstanding (worth $70.05M).